Regulatory News Service (RNS)

View all

Results, Reports and Presentations

• 2026 Investor Presentation

  January 8 2026 Download (1.01MB)

• Indivior Q3 2025 Financial Results

  October 30 2025 Download (394KB)

• October 2025 Investor Presentation

  October 30 2025 Download (2.36MB)

• July 2025 Investor Presentation

  July 31 2025 Download (1.70MB)

• Indivior Q2 2025 Financial Results

  July 31 2025 Download (392KB)

View all

Latest News

• Indivior Provides Full-Year 2026 Financial Guidance and Business Update

  January 8 2026

• Indivior Announces Inclusion in the S&P SmallCap 600® Index

  December 22 2025

• New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations

  December 17 2025

• Indivior Concludes Legacy U.S. Department of Justice Matter

  November 20 2025

• Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference

  November 19 2025

View all